Literature DB >> 6975113

Kinetics of Haemophilus influenzae type B infection in normal and ribosome-immunized mice using intraperitoneal and intracerebral routes of inoculation.

J P Burans, F H Kruszewski, M Lynn, M Solotorovsky.   

Abstract

The kinetics of infection was studied in normal and ribosome-immunized mice challenged with Haemophilus influenzae Type b organisms. Ribosomal preparations extracted by the differential-centrifugation and sodium-dodecyl-sulphate treatment or ammonium-sulphate-precipitation procedures were highly immunoprotective when mice were challenged by the i.p. route. After i.p. injections, organisms rapidly spread to blood, liver, lungs and brain in normal and immunized mice. However, by 24 h after injection, evidence of organism clearance could be seen in immunized mice. By 32 h organisms were cleared from blood, brain and lungs of all immunized mice and from spleens in 2 of 3 mice. However, organisms persisted in high numbers of unimmunized mice until their death by 48 h. These data indicate that i.p. injections of H. influenzae mixed with gastric mucin leads to a true infection and can be used as a model to evaluate immunoprotective activity. The kinetics of infection induced by intracerebral (i.c.) inoculation also was studied. The LD50 for this type of infection was more than 1000 times the LD50 for i.p. infection. The patterns of infection induced by i.c. challenge were similar in normal and immunized mice and immunoprotection could not be detected using this model.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975113      PMCID: PMC2041713     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  A defined medium for Haemophilus influenzae and Haemophilus parainfluenzae.

Authors:  L O BUTLER
Journal:  J Gen Microbiol       Date:  1962-01

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Haemophilus influenzae: immunology and immunoprotection.

Authors:  M Solotorovsky; M Lynn
Journal:  CRC Crit Rev Microbiol       Date:  1978-09

4.  Extraction and isolation of individual ribosomal proteins from Escherichia coli.

Authors:  S Fogel; P S Sypherd
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

5.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

6.  Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.

Authors:  R P Tewari; M Lynn; A J Birnbaum; M Solotorovsky
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Immunoprotective activity of ribosomes from Haemophilus influenzae.

Authors:  M Lynn; R P Tewari; M Solotorovsky
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

8.  Serological and biological activities of anti-Haemophilus influenzae ribosomal serum.

Authors:  M Katz; M Lynn; M Solotorovsky
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Meningitis caused by Haemophilus influenzae in infant rats: protective immunity and antibody priming by gastrointestinal colonization with Escherichia coli.

Authors:  E R Moxon; P Anderson
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

10.  Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.

Authors:  A L Smith; D H Smith; D R Averill; J Marino; E R Moxon
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

  10 in total
  2 in total

1.  Induction of active immunity with membrane fractions from Haemophilus influenzae type b.

Authors:  J P Burans; M Lynn; M Solotorovsky
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

2.  Lethal Haemophilus influenzae type b infection in mice.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.